{
 "companyname": "OXIGENE INC",
 "symbol": "OXGN",
 "description": "Biological Products, Except Diagnostic Substances",
 "quarters": [
  {
   "cik": "0000908259",
   "companyname": "OXIGENE INC",
   "entityid": 6739,
   "primaryexchange": "Nasdaq Capital Market",
   "primarysymbol": "OXGN",
   "siccode": "2836",
   "sicdescription": "Biological Products, Except Diagnostic Substances",
   "usdconversionrate": 1,
   "restated": false,
   "receiveddate": "11/12/2015",
   "preliminary": false,
   "periodlengthcode": "m",
   "periodlength": 3,
   "periodenddate": "9/30/2015",
   "original": true,
   "formtype": "10-Q",
   "fiscalyear": 2015,
   "fiscalquarter": 3,
   "dcn": "0001193125-15-375238",
   "currencycode": "USD",
   "crosscalculated": true,
   "audited": "false",
   "amended": false,
   "changeincurrentassets": 55000,
   "changeincurrentliabilities": 532000,
   "changeininventories": null,
   "dividendspaid": null,
   "effectofexchangerateoncash": null,
   "capitalexpenditures": 1000,
   "cashfromfinancingactivities": 0,
   "cashfrominvestingactivities": 1000,
   "cashfromoperatingactivities": -2843000,
   "cfdepreciationamortization": 5000,
   "changeinaccountsreceivable": null,
   "investmentchangesnet": null,
   "netchangeincash": -2842000,
   "totaladjustments": 749000,
   "ebit": -3599000,
   "costofrevenue": null,
   "discontinuedoperations": null,
   "equityearnings": null,
   "accountingchange": null,
   "extraordinaryitems": null,
   "grossprofit": null,
   "incomebeforetaxes": -3592000,
   "interestexpense": null,
   "netincome": -3592000,
   "netincomeapplicabletocommon": -3592000,
   "researchdevelopmentexpense": 2457000,
   "totalrevenue": null,
   "sellinggeneraladministrativeexpenses": 1142000,
   "commonstock": 265000,
   "deferredcharges": null,
   "cashandcashequivalents": 30251000,
   "cashcashequivalentsandshortterminvestments": 30251000,
   "goodwill": null,
   "intangibleassets": null,
   "inventoriesnet": null,
   "minorityinterest": null,
   "otherassets": 33000,
   "othercurrentassets": null,
   "othercurrentliabilities": null,
   "otherequity": null,
   "otherliabilities": null,
   "preferredstock": 0,
   "propertyplantequipmentnet": 36000,
   "retainedearnings": -260843000,
   "totalassets": 30736000,
   "totalcurrentassets": 30667000,
   "totalcurrentliabilities": 1698000,
   "totalliabilities": 1698000,
   "totallongtermdebt": null,
   "totalreceivablesnet": null,
   "totalshorttermdebt": null,
   "totalstockholdersequity": 29038000,
   "treasurystock": null
  },
  {
   "cik": "0000908259",
   "companyname": "OXIGENE INC",
   "entityid": 6739,
   "primaryexchange": "Nasdaq Capital Market",
   "primarysymbol": "OXGN",
   "siccode": "2836",
   "sicdescription": "Biological Products, Except Diagnostic Substances",
   "usdconversionrate": 1,
   "restated": false,
   "receiveddate": "8/6/2015",
   "preliminary": false,
   "periodlengthcode": "m",
   "periodlength": 3,
   "periodenddate": "6/30/2015",
   "original": true,
   "formtype": "10-Q",
   "fiscalyear": 2015,
   "fiscalquarter": 2,
   "dcn": "0001193125-15-280950",
   "currencycode": "USD",
   "crosscalculated": true,
   "audited": "false",
   "amended": false,
   "changeincurrentassets": 285000,
   "changeincurrentliabilities": 137000,
   "changeininventories": null,
   "dividendspaid": null,
   "effectofexchangerateoncash": null,
   "capitalexpenditures": null,
   "cashfromfinancingactivities": -12000,
   "cashfrominvestingactivities": null,
   "cashfromoperatingactivities": -2615000,
   "cfdepreciationamortization": 5000,
   "changeinaccountsreceivable": null,
   "investmentchangesnet": null,
   "netchangeincash": -2642000,
   "totaladjustments": 709000,
   "ebit": -3328000,
   "costofrevenue": null,
   "discontinuedoperations": null,
   "equityearnings": null,
   "accountingchange": null,
   "extraordinaryitems": null,
   "grossprofit": null,
   "incomebeforetaxes": -3324000,
   "interestexpense": null,
   "netincome": -3324000,
   "netincomeapplicabletocommon": -3324000,
   "researchdevelopmentexpense": 1981000,
   "totalrevenue": null,
   "sellinggeneraladministrativeexpenses": 1347000,
   "commonstock": 265000,
   "deferredcharges": null,
   "cashandcashequivalents": 33093000,
   "cashcashequivalentsandshortterminvestments": 33093000,
   "goodwill": null,
   "intangibleassets": null,
   "inventoriesnet": null,
   "minorityinterest": null,
   "otherassets": 33000,
   "othercurrentassets": null,
   "othercurrentliabilities": null,
   "otherequity": null,
   "otherliabilities": null,
   "preferredstock": 0,
   "propertyplantequipmentnet": 42000,
   "retainedearnings": -257251000,
   "totalassets": 33639000,
   "totalcurrentassets": 33564000,
   "totalcurrentliabilities": 1166000,
   "totalliabilities": 1166000,
   "totallongtermdebt": null,
   "totalreceivablesnet": null,
   "totalshorttermdebt": null,
   "totalstockholdersequity": 32473000,
   "treasurystock": null
  },
  {
   "cik": "0000908259",
   "companyname": "OXIGENE INC",
   "entityid": 6739,
   "primaryexchange": "Nasdaq Capital Market",
   "primarysymbol": "OXGN",
   "siccode": "2836",
   "sicdescription": "Biological Products, Except Diagnostic Substances",
   "usdconversionrate": 1,
   "restated": false,
   "receiveddate": "5/7/2015",
   "preliminary": false,
   "periodlengthcode": "m",
   "periodlength": 3,
   "periodenddate": "3/31/2015",
   "original": true,
   "formtype": "10-Q",
   "fiscalyear": 2015,
   "fiscalquarter": 1,
   "dcn": "0001193125-15-176991",
   "currencycode": "USD",
   "crosscalculated": false,
   "audited": "false",
   "amended": false,
   "changeincurrentassets": -434000,
   "changeincurrentliabilities": -390000,
   "changeininventories": null,
   "dividendspaid": null,
   "effectofexchangerateoncash": null,
   "capitalexpenditures": null,
   "cashfromfinancingactivities": 9207000,
   "cashfrominvestingactivities": null,
   "cashfromoperatingactivities": -3503000,
   "cfdepreciationamortization": 5000,
   "changeinaccountsreceivable": null,
   "investmentchangesnet": null,
   "netchangeincash": 5704000,
   "totaladjustments": -731000,
   "ebit": -2777000,
   "costofrevenue": null,
   "discontinuedoperations": null,
   "equityearnings": null,
   "accountingchange": null,
   "extraordinaryitems": null,
   "grossprofit": null,
   "incomebeforetaxes": -2772000,
   "interestexpense": null,
   "netincome": -2772000,
   "netincomeapplicabletocommon": -2772000,
   "researchdevelopmentexpense": 1669000,
   "totalrevenue": null,
   "sellinggeneraladministrativeexpenses": 1108000,
   "commonstock": 265000,
   "deferredcharges": null,
   "cashandcashequivalents": 35735000,
   "cashcashequivalentsandshortterminvestments": 35735000,
   "goodwill": null,
   "intangibleassets": null,
   "inventoriesnet": null,
   "minorityinterest": null,
   "otherassets": 33000,
   "othercurrentassets": 0,
   "othercurrentliabilities": null,
   "otherequity": null,
   "otherliabilities": null,
   "preferredstock": 0,
   "propertyplantequipmentnet": 32000,
   "retainedearnings": -253927000,
   "totalassets": 36555000,
   "totalcurrentassets": 36490000,
   "totalcurrentliabilities": 1029000,
   "totalliabilities": 1029000,
   "totallongtermdebt": null,
   "totalreceivablesnet": null,
   "totalshorttermdebt": null,
   "totalstockholdersequity": 35526000,
   "treasurystock": null
  }
 ]
}